📰 Derekj Maetzold News
Derekj Maetzold News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Derekj Maetzold. Real-time updates on events, politics, business and more.
June 12, 2024
Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) shares rose 8.8% during trading on Wednesday . The stock traded as high as $23.51 and last traded at $23.44. Approximately 139,605 shares were traded during trading, a decline of 42% from the average daily volume of 241,645 shares. The stock had previously closed at $21.55. Analyst […]
June 11, 2024
Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report)’s share price fell 4.7% during mid-day trading on Tuesday . The stock traded as low as $21.90 and last traded at $22.12. 111,875 shares traded hands during mid-day trading, a decline of 54% from the average session volume of 240,997 shares. The stock had previously closed at […]
June 6, 2024
Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) insider Derek J. Maetzold sold 2,368 shares of Castle Biosciences stock in a transaction on Monday, June 3rd. The stock was sold at an average price of $23.40, for a total transaction of $55,411.20. Following the transaction, the insider now directly owns 57,893 shares of the company’s […]
April 20, 2024
Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) insider Derek J. Maetzold sold 1,947 shares of the business’s stock in a transaction that occurred on Friday, April 12th. The shares were sold at an average price of $20.35, for a total value of $39,621.45. Following the completion of the transaction, the insider now directly owns […]
April 18, 2024
Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) insider Derek J. Maetzold sold 1,947 shares of the firm’s stock in a transaction that occurred on Friday, April 12th. The shares were sold at an average price of $20.35, for a total value of $39,621.45. Following the completion of the sale, the insider now directly owns […]
April 2, 2024
Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) was the recipient of a significant increase in short interest in March. As of March 15th, there was short interest totalling 1,420,000 shares, an increase of 17.4% from the February 29th total of 1,210,000 shares. Based on an average daily trading volume, of 252,100 shares, the short-interest […]
April 2, 2024
Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) was the recipient of a significant increase in short interest in the month of March. As of March 15th, there was short interest totalling 1,420,000 shares, an increase of 17.4% from the February 29th total of 1,210,000 shares. Based on an average trading volume of 252,100 shares, […]
March 23, 2024
Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) insider Derek J. Maetzold sold 2,295 shares of the firm’s stock in a transaction dated Wednesday, March 20th. The stock was sold at an average price of $20.27, for a total transaction of $46,519.65. Following the transaction, the insider now owns 69,806 shares of the company’s stock, […]
February 28, 2024
Deerfield Management Company L.P. Series C bought a new position in shares of Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 946,620 shares of the company’s stock, valued at approximately $15,988,000. Deerfield Management Company L.P. Series […]
February 14, 2024
Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) was the target of a large growth in short interest during the month of January. As of January 31st, there was short interest totalling 1,240,000 shares, a growth of 29.3% from the January 15th total of 958,800 shares. Currently, 5.0% of the company’s shares are short sold. […]